209 related articles for article (PubMed ID: 31321234)
1. Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview.
Qiu L; Guo C; Hua B
Biomed Res Int; 2019; 2019():3808594. PubMed ID: 31321234
[TBL] [Abstract][Full Text] [Related]
2. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease.
Qiu L; Guo C
Curr Drug Targets; 2020; 21(6):599-609. PubMed ID: 31589122
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of aldose reductase ameliorates alcoholic liver disease by activating AMPK and modulating oxidative stress and inflammatory cytokines.
Shi C; Wang Y; Gao J; Chen S; Zhao X; Cai C; Guo C; Qiu L
Mol Med Rep; 2017 Sep; 16(3):2767-2772. PubMed ID: 28677809
[TBL] [Abstract][Full Text] [Related]
4. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease.
Wang M; Chen WY; Zhang J; Gobejishvili L; Barve SS; McClain CJ; Joshi-Barve S
Hepatology; 2020 Nov; 72(5):1617-1637. PubMed ID: 32086945
[TBL] [Abstract][Full Text] [Related]
5. Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of Medicative Agents for Fatty Liver Disease.
Wang T; Xu ZH
Comb Chem High Throughput Screen; 2023; 26(11):1929-1944. PubMed ID: 36655533
[TBL] [Abstract][Full Text] [Related]
6. Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model.
Zhang P; Qiang X; Zhang M; Ma D; Zhao Z; Zhou C; Liu X; Li R; Chen H; Zhang Y
J Pharmacol Exp Ther; 2015 Jan; 352(1):139-47. PubMed ID: 25362106
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
Ceni E; Mello T; Galli A
World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.
Qiu LX; Chen T
World J Gastroenterol; 2015 Jan; 21(4):1099-107. PubMed ID: 25632182
[TBL] [Abstract][Full Text] [Related]
9. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
[TBL] [Abstract][Full Text] [Related]
10. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
ElGamal H; Munusamy S
Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
[TBL] [Abstract][Full Text] [Related]
11. Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes.
Han KH; Hashimoto N; Fukushima M
World J Gastroenterol; 2016 Jan; 22(1):37-49. PubMed ID: 26755859
[TBL] [Abstract][Full Text] [Related]
12. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective effects on alcoholic liver disease of fermented silkworms with Bacillus subtilis and Aspergillus kawachii.
Cha JY; Kim YS; Moon HI; Cho YS
Int J Food Sci Nutr; 2012 Aug; 63(5):537-47. PubMed ID: 21838591
[TBL] [Abstract][Full Text] [Related]
14. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence.
Ghorbani Z; Hajizadeh M; Hekmatdoost A
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):348-60. PubMed ID: 27498574
[TBL] [Abstract][Full Text] [Related]
15. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.
Zou Y; Qin X; Hao X; Zhang W; Yang S; Yang Y; Han Z; Ma B; Zhu C
Bioorg Med Chem Lett; 2015 Sep; 25(18):3924-7. PubMed ID: 26227780
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective potential of Aloe vera polysaccharides against chronic alcohol-induced hepatotoxicity in mice.
Cui Y; Ye Q; Wang H; Li Y; Yao W; Qian H
J Sci Food Agric; 2014 Jul; 94(9):1764-71. PubMed ID: 24272968
[TBL] [Abstract][Full Text] [Related]
17. Effects of aldose reductase inhibitors on antioxidant defense in rat and rabbit liver.
Thomas T; Rauscher F; Sanders R; Veltman J; Watkins JB
Toxicol Sci; 2000 Jan; 53(1):145-9. PubMed ID: 10653532
[TBL] [Abstract][Full Text] [Related]
18. Polydatin alleviated alcoholic liver injury in zebrafish larvae through ameliorating lipid metabolism and oxidative stress.
Lai Y; Zhou C; Huang P; Dong Z; Mo C; Xie L; Lin H; Zhou Z; Deng G; Liu Y; Chen Y; Huang S; Wu Z; Sun X; Gao L; Lv Z
J Pharmacol Sci; 2018 Sep; 138(1):46-53. PubMed ID: 30245287
[TBL] [Abstract][Full Text] [Related]
19. A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.
Han Z; Hao X; Ma B; Zhu C
Eur J Med Chem; 2016 Oct; 121():308-317. PubMed ID: 27267001
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis.
Guo C; Chen L; Huang J; Wang Y; Shi C; Gao J; Hong Y; Chen T; Qiu L
Chem Biol Interact; 2018 May; 287():41-48. PubMed ID: 29630881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
